我国2011-2015年降压药药物经济学研究文献系统评价  

Systematic Evaluation of the Economic Research Literatures on Antihypertensive Drugs in China Published during 2011-2015

作　　者：王艳春[1] 吕巧莉[1] 孙建勋[1] 

机构地区：[1]河南大学药学院,开封475004

出　　处：《中国药事》2016年第7期646-654,共9页Chinese Pharmaceutical Affairs

摘　　要：目的:探究我国在高血压药物治疗过程中药物经济学评价方法的应用现状及不足,比较成本效果相对较优的治疗方案。方法:在中国学术期刊全文数据库(CNKI)上检索与筛选使用药物经济学方法评价高血压药物治疗方案的有效文献,纳入2011-2015年的随机临床干预研究文献,进行综合评估分析。结果:共获得有效文献18篇,研究设计均采用回顾性分析,仅1篇进行了调查与随访。研究数据均来自医院,比较了不同降压药的成本效果。结论:我国研究者在进行高血压药物治疗过程中,药物经济学研究存在方法单一,各个研究不具有可比性,模型技术运用不足等问题。Objective： To explore the current situation and problems of the application of economic evaluation method in the process of drug treatment for hypertension, and to compare the treatment plan with the cost effect. Methods： The Chinese academic journal full text database（CNKI） was searched and screened for effective literatures using drug economics method to evaluate the treatment of hypertension drugs, and a comprehensive assessment of the literatures on the study of randomized clinical intervention from 2011 to 2015 was conducted. Results： A total of 18 valid literatures were obtained, and the design of the study was analyzed retrospectively, finding that only 1 involved investigation and follow-up, while all others adopted retrospective analysis. The research data were all from hospital data, and the cost effect of different antihypertensive drugs was compared. Conclusion： In the process of drug treatment of hypertension, there are several problems with drug economics study such as using a single method, lacking comparability among studies, and insufficient employment of modeling.

关 键 词：降压药 药物经济学 系统评价 

分 类 号：R972.4[医药卫生—药品]